Patents Assigned to BOEHRINGER INGELHEIM PHARMA GBMH CO. KG
  • Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
    Patent number: 8518377
    Abstract: The invention relates to pressurized gas formulations for dosage aerosols, in which a medicament is formulated suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane) as a propellant, and to their use for producing a medicament. The aerosol is preferably an inhalation aerosol.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: August 27, 2013
    Assignee: Boehringer Ingelheim Pharma GbmH Co. KG
    Inventors: Hubert Hoelz, Mariola Mann, Christel Schmelzer, Friedrich Schmidt, Hans-Hermann Weil
  • Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
    Publication number: 20090092559
    Abstract: The invention relates to pressurized gas formulations for dosage aerosols, in which a medicament is formulated suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane) as a propellant, and to their use for producing a medicament. The aerosol is preferably an inhalation aerosol.
    Type: Application
    Filed: April 4, 2007
    Publication date: April 9, 2009
    Applicant: BOEHRINGER INGELHEIM PHARMA GBMH CO. KG
    Inventors: Hubert Hoelz, Mariola Mann, Christel Schmelzer, Friedrich Schmidt, Hans-Hermann Weil